Malcolm VandenBurg

Malcolm VandenBurg is an English doctor involved in drug research, sexual health, medicolegal advice and stress management.[1]

Medical career

VandenBurg qualified in St Bartholomew’s Hospital in 1973 with a BSc in Physiology.

He lectured in medicine, as an Honorary Senior Registrar at the London Hospital and as an Honorary Lecturer in Clinical Pharmacology at St Bartholomew's Hospital

VandenBurg is a Fellow of the Royal College of Physicians, the American College of Clinical Pharmacology and the Faculty of Pharmaceutical Medicine

He established the London Hospital Hypertension Clinic in 1975.[2]

Research

VandenBurg was Director of Cardiovascular Research, Old Church Hospital Romford (1984–1996) and Director of Clinical Research at Merck Sharpe & Dohme (1980–1984)

In 1996 he was appointed President and Chief Executive Officer of global research consultancy IBRD - Rostrum Inc.[3]

VandenBurg has coordinated drug development programmes for over 30 pharmaceutical products and has over 100 publications in the field of clinical research. [2]

Medicolegal Work

VandenBurg is a registered expert witness[4] who has given medicolegal advice to courts, authorities and media in a number of high-profile cases.[5]

He has written in the BMJ about the medicolegal implications of newer SSRIs[6] and of driving while under the influence of cannabis[7]

VandenBurg was an expert witness in the case of the Death of Sean Rigg in police custody in 2008.[4] He also advised the Northern Ireland Prisoner Ombudsman on the deaths of Aaron Hogg in Maghaberry Prison in 2011.[8] and Frances McKeown in Hydebank Wood Prison,[9] both in 2011.

VandenBurg advised the UK press on the use of propofol in the Death of Michael Jackson.[10][11]

Key Publications

Books

References

External links

This article is issued from Wikipedia - version of the 11/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.